Back to 
Zacks Investment Management
Zacks Investment Management
RLAY
2 quarters
Position history for Zacks Investment Management's holdings in Relay Therapeutics, Inc.
No. Zacks Investment Management exited its RLAY (Relay Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 15,307 shares worth $52,964. Zacks Investment Management first reported RLAY in Q2 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$52,964
Total Shares Change
-15,307
Quarter-by-Quarter History